JDD Issue Highlights | May 2022
The May 2022 issue of the Journal of Drugs in Dermatology (JDD) focuses on skin cancer and features other topics such as fungal infections, updates on new topical advances, and Mohs micrographic surgery. We share this month’s issue highlights straight from the JDD Editor’s desk:
Insights in Skin of Color Patients With Atopic Dermatitis and the Role of Skincare in Improving Outcomes concludes …
The May 2022 issue of the Journal of Drugs in Dermatology (JDD) focuses on skin cancer and features other topics such as fungal infections, updates on new topical advances, and Mohs micrographic surgery. We share this month’s issue highlights straight from the JDD Editor’s desk:
Insights in Skin of Color Patients With Atopic Dermatitis and the Role of Skincare in Improving Outcomes concludes … 
Atopic dermatitis is a heterogeneous, chronic inflammatory disease that affects upwards of 10% of children and 7% of adults in the United States. Despite being an incredibly common skin concern among patients, AD continues to pose diagnostic and treatment challenges to dermatologists.
What are some common misconceptions about AD?
AD always starts in childhood. FALSE. 25% of adults w … 
A father brings in his child who has a history of atopic dermatitis. He reports a one-week history of blisters on the extremities and states this looks different than his usual eczema. The child is well appearing and happily cooperative with your exam. What is the next step in management?
A. Scabies prep
B. Wound culture
C. Tzanck smear
D. Potassium hydroxide prep
E. Punch b … 
The March 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from acne and psoriasis to Platelet Rich Plasma (PRP) for scarring alopecia and racial differences and their impact on treatment for hidradenitis suppurativa, we share this month’s issue highlights straight from the JDD Editor’s de … 
Next Steps in Derm, in partnership with ODAC Dermatology, Aesthetic and Surgical Conference, interviewed Dr. Adam Friedman (Professor and Chair of Dermatology who serves as Associate Residency Program Director, Director of Translational Research, and Director of the Supportive Oncodermatology Program in the GW Department of Dermatology) about the latest in Atopic Dermatitis (AD). Watch as he discu … 